ArticlePloS one2014

Optical imaging for monitoring tumor oxygenation response after initiation of single-agent bevacizumab followed by cytotoxic chemotherapy in breast cancer patients.

Shigeto Ueda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.